News Releases

UTHSC, UTSA ink San Antonio Life Sciences Institute pact

December 9, 2003

Francisco G. Cigarroa, M.D., president of The University of Texas Health Science Center at San Antonio (UTHSC), and Ricardo Romo, Ph.D., president of The University of Texas at San Antonio, signed an agreement Monday (Dec. 1) that provides governing guidelines for the new San Antonio Life Sciences Institute (SALSI), an initiative designed to strengthen collaboration between the two institutions and enhance their research, teaching and service missions.


UTHSC selects Denver partner for $2.8 million asthma study

December 9, 2003

The University of Texas Health Science Center at San Antonio (UTHSC) has contracted with National Jewish Medical and Research Center of Denver, Colo., to provide telephone and mail patient support for a large-scale study evaluating the benefits of disease management among individuals with moderate to severe asthma.


Cigarroa announces $300 million capital campaign for UTHSC

December 9, 2003

The University of Texas Health Science Center at San Antonio (UTHSC) is embarking on its first capital campaign – a $300 million private-public initiative to build a landscape-changing Research Tower in the South Texas Medical Center and recruit leading scientists for it.


TIME magazine highlights UTHSC research on ADHD

December 3, 2003

The cover story in the Nov. 3 issue of TIME magazine, “Medicating Young Minds,” discusses the benefits and risks of medicating children with mood and behavior problems.


Portable blood analyzer picks up cases of anemia in Mexican children

December 2, 2003

A portable blood analyzer developed at The University of Texas Health Science Center at San Antonio (UTHSC) and commercialized by AVOX Systems of San Antonio helped diagnose a young child with anemia recently during a visit to a children’s home in Nuevo Laredo, Mexico.


UTHSC to co-sponsor conference on Cancer-Induced Bone Diseases

December 2, 2003

t least 300 of the world’s best-known researchers in the field of bone metastasis and myeloma are expected to attend the IVth International Conference on Cancer-Induced Bone Diseases Dec. 7-9 in San Antonio, Texas.